Published in J Exp Med on August 01, 1977
Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. J Exp Med (1980) 1.72
Specificity of a mycoplasma mitogen for lymphocytes from human and various animal hosts. Infect Immun (1982) 0.87
Evidence for extensive polymorphism of class I genes in the rat major histocompatibility complex (RT1). Proc Natl Acad Sci U S A (1983) 0.87
Immunosuppressive ALS. II. Antibody to Ia antigens in heterologous anti-lymphocyte serum. Immunology (1979) 0.75
Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol (1975) 47.77
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19
A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. J Exp Med (1973) 5.55
An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci. J Immunol (1976) 4.55
Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med (1974) 3.29
Evidence for identity or close association of the Fc receptor of B lymphocytes and alloantigens determined by the Ir region of the H-2 complex. J Exp Med (1974) 3.07
Isolation of glycoproteins from pig lymphocyte plasma membrane using Lens culinaris phytohemagglutinin. Biochem Biophys Res Commun (1972) 3.05
Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization. J Exp Med (1975) 2.78
Structural and serological properties of murine Ia alloantigens. Transplant Rev (1976) 2.35
Antigen-specific thymus cell factors in the genetic control of the immune response to poly-(tyrosyl, glutamyl)-poly-D, L-alanyl--poly-lysyl. J Exp Med (1974) 2.19
Separation of murine lymphoid cells using nylon wool columns. Recovery of the B cell-enriched population. Transplantation (1974) 2.10
Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08
Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. J Immunol (1975) 1.65
Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant. J Immunol (1976) 1.46
Guinea-pig Ia antigens: functional significance and chemical characterization. Transplant Rev (1976) 1.44
Chemical properties of human Ia antigens. Nature (1977) 1.40
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33
Human lymphocyte alloantigen(s) similar to murine Ir region-associated (Ia) antigens. J Immunol (1975) 1.32
Partial characterisation of Ia antigens on murine thymocytes. Nature (1975) 1.18
Separation of anti-Ia (I-region associated antigens) from anti-H-2 antibodies in complex sera, by absorption on blood platelets. description of three new Ia specificities. Tissue Antigens (1976) 1.09
B-cell antibodies, Ia-like determinants, and their relation to MLC determinants in man. Transplant Rev (1976) 1.02
Ir-associated murine alloantigens: demonstration of multiple Ia specificities in H-2 alloantisera after selective absorptions. J Immunol (1975) 1.01
Specific human B lymphocyte alloantigens linked to HL-A. Proc Natl Acad Sci U S A (1975) 0.91
Serologic cross-reactivity between H-2 and HL-A antigens. I. Specific reactivity of rabbit anti-HL-A sera against murine cells. J Immunol (1972) 0.87
Histocompatibility relationships between species. Transplant Proc (1971) 0.78
Cross-reactions between the major histocompatibility system of man and mice (HL-A and H-2). Cytotoxic action of anti-H-2 sera on lymphocytes. Tissue Antigens (1975) 0.78
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol (1981) 6.75
Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol (1979) 6.70
Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature (1979) 5.58
A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. J Exp Med (1973) 5.55
Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature (1984) 4.26
Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation (1982) 4.11
Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation (1976) 3.41
Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol (1980) 3.39
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med (1989) 3.34
Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med (1974) 3.29
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
Evidence for identity or close association of the Fc receptor of B lymphocytes and alloantigens determined by the Ir region of the H-2 complex. J Exp Med (1974) 3.07
T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera. J Immunol (1976) 2.64
Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol (1984) 2.62
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med (2000) 2.61
A subpopulation of adherent accessory cells bearing both I-A and I-E or C subregion antigens is required for antigen-specific murine T lymphocyte proliferation. J Immunol (1978) 2.54
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus. J Exp Med (1979) 2.39
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet (1999) 2.26
The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat. J Immunol (1971) 2.17
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation (1999) 2.16
Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade. Transplantation (2002) 2.15
Resistance to Listeria monocytogenes in mice: genetic control by genes that are not linked to the H-2 complex. J Infect Dis (1979) 2.09
Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med (1985) 2.00
Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation (2000) 1.88
Skin graft tolerance across a discordant xenogeneic barrier. Nat Med (1996) 1.86
Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest (2000) 1.86
An immunologic approach to the conformational equilibria of polypeptides. Proc Natl Acad Sci U S A (1972) 1.85
Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells. J Immunol (1985) 1.83
Association of polyoma T antigen and DNA with the nuclear matrix from lytically infected 3T6 cells. Cell (1980) 1.78
IA mutant functional antigen-presenting cell lines. J Immunol (1983) 1.76
Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest (2000) 1.74
B-cell alloantigens determined by the H-2 linked Ir region are associated with mixed lymphocyte culture stimulation. Science (1974) 1.73
A genomic view of the sea urchin nervous system. Dev Biol (2006) 1.68
H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins. J Exp Med (1978) 1.68
Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation (1999) 1.66
Studies of Ia antigens on murine peritoneal macrophages. Scand J Immunol (1976) 1.66
Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. J Immunol (1975) 1.65
Thymic transplantation in miniature swine. I. Development and function of the "thymokidney". Transplantation (1999) 1.64
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J Immunol (1988) 1.63
Skin-specific alloantigens in miniature swine. Transplantation (2001) 1.62
Evidence for a role of Ir-associated alloantigens in mixed lymphocyte culture stimulation. J Exp Med (1974) 1.62
Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation (2004) 1.56
Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine. Transplantation (1992) 1.56
The induction of tolerance of renal allografts by adoptive transfer in miniature swine. Am J Transplant (2013) 1.56
The T cell repertoire for recognition of a phylogenetically distant protein antigen. Peptide specificity and MHC restriction of staphylococcal nuclease-specific T cell clones. J Exp Med (1986) 1.55
Tolerance in a concordant nonhuman primate model. Transplantation (1999) 1.53
Ia antigens in mouse skin are predominantly expressed on Langerhans cells. J Immunol (1979) 1.53
Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex. J Immunol (1976) 1.49
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant (2014) 1.49
Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine. Transplantation (1981) 1.49
Evidence for a major QTL associated with host response to porcine reproductive and respiratory syndrome virus challenge. J Anim Sci (2011) 1.49
Xenogeneic transplantation. Annu Rev Immunol (1998) 1.48
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis (1996) 1.46
Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant. J Immunol (1976) 1.46
Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation (1997) 1.45
Discordant organ xenotransplantation in primates: world experience and current status. Transplantation (1998) 1.45
Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med (1997) 1.44
Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood (1994) 1.44
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
Infectivity of low numbers of Toxoplasma gondii oocysts to pigs. J Parasitol (1996) 1.43
Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. J Immunol (1978) 1.41
Specific transplantation tolerance. N Engl J Med (1991) 1.41
Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J Immunol (1986) 1.40
Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant (2010) 1.39
Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10). J Immunol (1986) 1.39
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
Antibodies to a distinct antigenic determinant of staphylococcal nuclease. J Immunol (1972) 1.37
Genetic control of the immune response to staphylococcal nuclease. I. Ir-Nase: control of the antibody response to nuclease by the Ir region of the mouse H-2 complex. J Exp Med (1974) 1.36
An immunological approach to the conformational equilibrium of staphylococcal nuclease. J Mol Biol (1975) 1.36
Chimerism and transplantation tolerance: cause and effect. Immunol Today (1996) 1.35
Immunochemical evidence for an additional H-2 region closely linked to H-2D. J Exp Med (1977) 1.33
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant (2000) 1.33
Mouse alloantibodies capable of blocking cytotoxic T cell function. II. Further study on the relationship between the blocking antibodies and the products of the Lyt-2 locus. Eur J Immunol (1980) 1.33
Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today (1988) 1.33
Human lymphocyte alloantigen(s) similar to murine Ir region-associated (Ia) antigens. J Immunol (1975) 1.32
Induction of anti-H-2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype. Nature (1981) 1.30
Immunochemical evidence in two haplotypes for at least three D region-encoded molecules, D, L, and R. J Immunol (1981) 1.29
Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. Transplantation (2001) 1.27
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant (2009) 1.27
Nomenclature for factors of the SLA system, update 2008. Tissue Antigens (2009) 1.26
Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol (1995) 1.26
Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies. J Exp Med (1984) 1.25
Mixed chimerism. Philos Trans R Soc Lond B Biol Sci (2001) 1.24
Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens. J Exp Med (1985) 1.23
Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation (1998) 1.23
Mutation in a new H-2-associated histocompatibility gene closely linked to H-2D. J Exp Med (1977) 1.23
Heterogeneity of H-2D region associated genes and gene products. Adv Immunol (1983) 1.21
Peripheral tolerance to class I mismatched renal allografts in miniature swine: donor antigen-activated peripheral blood lymphocytes from tolerant swine inhibit antidonor CTL reactivity. J Immunol (1999) 1.21
Genetic control of the immune response to staphylococcal nuclease. III. Time-course and correlation between the response to native nuclease and the response to its polypeptide fragments. J Exp Med (1977) 1.20
Rapid solid-phase synthesis of bradykinin. Biochem Biophys Res Commun (1972) 1.20
Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant (2011) 1.20